TAM
Tiverton Asset Management Portfolio holdings
AUM
$2.88B
1-Year Return
5.62%
This Quarter Return
-13.81%
1 Year Return
+5.62%
3 Year Return
+61.7%
5 Year Return
+105.17%
10 Year Return
–
AUM
$1.66B
AUM Growth
-$371M
(-18%)
Cap. Flow
-$76.5M
Cap. Flow
% of AUM
-4.6%
Top 10 Holdings %
Top 10 Hldgs %
36.06%
Holding
527
New
118
Increased
122
Reduced
98
Closed
37
Top Buys
| 1 |
Amazon
AMZN
|
$13.5M |
| 2 |
Cigna
CI
|
$12.9M |
| 3 |
Union Pacific
UNP
|
$9.19M |
| 4 |
Linde
LIN
|
$7.59M |
| 5 |
Merck
MRK
|
$5.44M |
Top Sells
Sector Composition
| 1 | Technology | 18.8% |
| 2 | Healthcare | 16.28% |
| 3 | Consumer Discretionary | 12.55% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
ResMed
RMD
$40.6B
| $218K | 0.01% |
1,911
| – | – |
|
302
Broadridge
BR
$29.4B
| $215K | 0.01% |
2,237
+337
| +18% | +$32.4K |
|
|
TWTR
303
DELISTED
Twitter, Inc.
TWTR
| $208K | 0.01% |
7,240
-878
| -11% | -$25.2K |
|
|
ABMD
304
DELISTED
Abiomed Inc
ABMD
| $207K | 0.01% |
637
| – | – |
|
305
Comerica
CMA
$8.85B
| $202K | 0.01% |
2,939
-11,707
| -80% | -$805K |
|
306
Gilead Sciences
GILD
$143B
| $202K | 0.01% |
3,235
| – | – |
|
307
F5
FFIV
$18.1B
| $201K | 0.01% |
1,237
+124
| +11% | +$20.1K |
|
308
Kura Oncology
KURA
$713M
| $198K | 0.01% |
14,110
-112,939
| -89% | -$1.58M |
|
309
Labcorp
LH
$23.2B
| $197K | 0.01% |
1,812
| – | – |
|
|
ANSS
310
DELISTED
Ansys
ANSS
| $196K | 0.01% |
1,372
+82
| +6% | +$11.7K |
|
311
Skyworks Solutions
SWKS
$11.2B
| $195K | 0.01% |
2,918
+107
| +4% | +$7.15K |
|
312
Western Digital
WDC
$31.9B
| $193K | 0.01% |
6,893
+12
| +0.2% | +$336 |
|
313
Zimmer Biomet
ZBH
$20.9B
| $193K | 0.01% |
1,920
| – | – |
|
314
AstraZeneca
AZN
$253B
| $192K | 0.01% |
5,060
| – | – |
|
315
Incyte
INCY
$16.9B
| $192K | 0.01% |
3,017
| – | – |
|
|
WP
316
DELISTED
Worldpay, Inc.
WP
| $192K | 0.01% |
+2,510
| New | +$192K |
|
|
WCG
317
DELISTED
Wellcare Health Plans, Inc.
WCG
| $189K | 0.01% |
800
| – | – |
|
318
KLA
KLAC
$119B
| $182K | 0.01% |
2,033
+110
| +6% | +$9.85K |
|
319
Cardinal Health
CAH
$35.7B
| $179K | 0.01% |
4,010
| – | – |
|
320
General Mills
GIS
$27B
| $177K | 0.01% |
4,547
| – | – |
|
321
Workday
WDAY
$61.7B
| $176K | 0.01% |
+1,105
| New | +$176K |
|
322
Henry Schein
HSIC
$8.42B
| $174K | 0.01% |
2,820
| – | – |
|
323
Alibaba
BABA
$323B
| $172K | 0.01% |
1,256
-17,292
| -93% | -$2.37M |
|
324
Y-mAbs Therapeutics
YMAB
$390M
| $170K | 0.01% |
8,338
-4,742
| -36% | -$96.7K |
|
325
Hologic
HOLX
$14.8B
| $169K | 0.01% |
4,101
| – | – |
|